Ten year experience of using a novel metabolic protocol in 'off pump' coronary artery bypass revascularization
Conclusions:
Off-pump coronary artery bypass coupled with this novel metabolic protocol was associated with a low operative mortality and acceptable perioperative morbidities, including patients with left main coronary artery disease. These benefits are apparent at both short- and medium-term follow up.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Perkowski, D. J., Wagner, S., Muller, K., Schneider, J. R., St.Cyr, J. A. Tags: Original Research Source Type: research
More News: Allopurinol | Angioplasty | Aspirin | Beta-Blockers | Cardiogenic Shock | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholesterol | Clopidogrel | Coronary Angioplasty | Coronary Artery Bypass Graft | Corticosteroid Therapy | Dialysis | Heart | Insulin | Magnesium | Plavix | Renal Failure | Statin Therapy | Stroke